Article
Polymorphisms in CYP2D6 duplication-negative individuals with the ultrarapid metabolizer phenotype: a role for the CYP2D6*35 allele in ultrarapid metabolism?
Pharmacogenetics - 1 Feb 2001
Løvlie R, Daly A K, Matre G E, Molven A, Steen V M
Abstract excerpt
Ultrarapid drug metabolism mediated by CYP2D6 is associated with inheritance of alleles with duplicated or amplified functional CYP2D6 genes. However, genotyping for duplicated CYP2D6 alleles only explains a fraction (10-30%) of the ultrarapid metabolizer phenotypes observed in Caucasian populations. Using a sample of CYP2D6 duplication-negative ultrarapid metabolizer subjects and selected control subjects with...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
